AMLODIPINE-OLMESARTAN 10-20 MG

Amlodipine besylate and Olmesartran medoxomil
$0.2849per EA

Strength

10; 20 mg/1; mg/1

NDC

62332021430

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207073

On Market Since

7/18/2017

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price History

1W

0.0%

1M

-6.4%

3M

-13.7%

6M

-11.5%

1Y

-22.4%

3Y

-44.8%

5Y

-41.8%

All

-70.4%